The FDA’s Reclassification of IVDs and Implications for LDTs Posted on March 22, 2024 (March 22, 2024) […] Read More… from The FDA’s Reclassification of IVDs and Implications for LDTs
MDC Welcomes Matthew Faron, PhD Posted on March 7, 2024 (March 7, 2024) […] Read More… from MDC Welcomes Matthew Faron, PhD
Matthew Faron, PhD Posted on February 29, 2024 (February 29, 2024) […] Read More… from Matthew Faron, PhD
Updates from Jan 2024 CLSI AST Subcommitee and Working Groups Posted on February 20, 2024 (February 21, 2024) […] Read More… from Updates from Jan 2024 CLSI AST Subcommitee and Working Groups
EU Commission Proposes Extension of IVDR Compliance Deadlines Posted on January 30, 2024 (January 30, 2024) […] Read More… from EU Commission Proposes Extension of IVDR Compliance Deadlines
FDA and CMS Reject the Notion of Expanding CLIA to Oversee LDTs Posted on January 23, 2024 (January 24, 2024) […] Read More… from FDA and CMS Reject the Notion of Expanding CLIA to Oversee LDTs
Lauren Jones, WHNP Posted on January 22, 2024 (January 22, 2024) […] Read More… from Lauren Jones, WHNP
FDA’s Proposed Regulations for Laboratory Developed Tests Posted on January 11, 2024 (January 11, 2024) […] Read More… from FDA’s Proposed Regulations for Laboratory Developed Tests
MDC Associates selected as a spoke of ARPA-H Investor Catalyst Hub network Posted on December 15, 2023 (January 11, 2024) […] Read More… from MDC Associates selected as a spoke of ARPA-H Investor Catalyst Hub network
Breakthrough Devices: Recent Changes and Expanding Initiatives by FDA Posted on October 31, 2023 (January 11, 2024) […] Read More… from Breakthrough Devices: Recent Changes and Expanding Initiatives by FDA